Cargando…
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti‐integrin therapies
Inflammatory bowel disease (IBD) is characterized by uncontrolled inflammation in the gastrointestinal tract. The underlying pathobiology of IBD includes an increase in infiltrating gut‐homing lymphocytes. Although lymphocyte homing is typically a tightly regulated and stepwise process involving mul...
Autores principales: | Dotan, Iris, Allez, Matthieu, Danese, Silvio, Keir, Mary, Tole, Swati, McBride, Jacqueline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973243/ https://www.ncbi.nlm.nih.gov/pubmed/31215680 http://dx.doi.org/10.1002/med.21601 |
Ejemplares similares
-
The Multiple Faces of Integrin–ECM Interactions in Inflammatory Bowel Disease
por: Garlatti, Valentina, et al.
Publicado: (2021) -
Regulation and Role of αE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease
por: Keir, Mary E., et al.
Publicado: (2021) -
Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti‐β7 integrin therapy for inflammatory bowel disease
por: Tang, M. T., et al.
Publicado: (2018) -
Anti-integrin therapy for inflammatory bowel disease
por: Park, Sung Chul, et al.
Publicado: (2018) -
Anti-Integrins for the Treatment of Inflammatory Bowel Disease: Current Evidence and Perspectives
por: Gubatan, John, et al.
Publicado: (2021)